EP2862860
1,3-oxasólídín- eða 1,3-oxasínanefnasambönd sem órexínviðtakamótverkendur
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.6.2013EP published:
21.12.2016EP application number:
13804876.4
EP translation filed:
9.1.2017Grant published:
15.2.2017EPO information:
European Patent Register
Max expiry date:
12.6.2033Expiry date:
12.6.2026Next due date:
30.6.2026
Title:
1,3-OXAZOLIDINE OR 1,3-OXAZINANE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
Timeline
Today
13.6.2013EP application
21.12.2016EP Publication
9.1.2017Translation submitted
15.2.2017Registration published
12.6.2026Expires
Owner
Name:
Taisho Pharmaceutical Co., Ltd.Address:
24-1, Takada 3-chome Toshima-ku, 170-8633, Tokyo, JP
Inventor
Name:
FUTAMURA AyaAddress:
Tokyo, JP
Name:
ARAKI YukoAddress:
Tokyo, JP
Name:
ABE MasahitoAddress:
Tokyo, JP
Name:
OHTA HiroshiAddress:
Tokyo, JP
Name:
SUZUKI RyoAddress:
Tokyo, JP
Name:
NOZAWA DaiAddress:
Tokyo, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2012135277Date:
15.6.2012Country:
JP
Classification
Categories:
C07D 413/14, A61K 31/4439, A61K 31/5355, A61P 1/04, A61P 1/14, A61P 3/00, A61P 9/12, A61P 25/06, A61P 25/08, A61P 25/14, A61P 25/16, A61P 25/18, A61P 25/20, A61P 25/22, A61P 25/24, A61P 25/28, A61P 25/36, A61P 29/00, A61P 37/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 21.6.2017
Expires: 12.6.2018
Payer: Árnason Faktor
Number: 6
Paid: 18.5.2018
Expires: 12.6.2019
Payer: G. H. Sigurgeirsson
Number: 7
Paid: 21.5.2019
Expires: 12.6.2020
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 14.4.2020
Expires: 12.6.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 10.6.2021
Expires: 12.6.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 13.6.2022
Expires: 12.6.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 15.6.2023
Expires: 12.6.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 11.6.2024
Expires: 12.6.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 13
Paid: 10.6.2025
Expires: 12.6.2026
Payer: G.H. Sigurgeirsson ehf.